DexCom, Inc. (0A4M)
LSE
Closed
Aug 5, 2026
Day's Range
85.4652 wk Range
56.00Overview - 0A4M - DexCom, Inc.
Key Statistics
Valuation
Enterprise Value
31.70B
P/E (Trailing)
‪1.74‬
PEG Ratio
‪-0.03‬
Price / Book
‪12.30‬
EV / EBITDA
‪22.59‬
Profitability
Gross Margin
‪84.50%‬
Profit Margin
‪20.11%‬
Operating Margin
‪24.32%‬
Return on Assets
‪10.33%‬
Return on Equity
‪38.49%‬
Ownership
Shares Outstanding
305.47M
Float
375.95M
Held by Insiders
‪0.27%‬
Held by Institutions
‪106.34%‬
Price stats
Beta
‪1.41‬
50-Day Avg
‪123.50‬
200-Day Avg
‪113.53‬
Dividends
Frequency
Quarterly
Peers - 0A4M - DexCom, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on LSE.
- 0A4MLSEDexcom Inc.+8.40%52-week change1.75P/E (Trailing)‪20.11%‬Profit Margin
- ECORLSEEcora Royalties PLC+57.91%52-week change24.23P/E (Trailing)‪39.68%‬Profit Margin
- AOTILSEAoti Inc.+58.63%52-week change135.00P/E (Trailing)‪4.00%‬Profit Margin
- CFXLSEColefax Group PLC+40.97%52-week change10.21P/E (Trailing)‪6.68%‬Profit Margin
- 0HKDLSEAxogen Inc.+67.86%52-week change—P/E (Trailing)‪-13.35%‬Profit Margin
- 0K5ELSEDrägerwerk AG & Co. KGaA - Preferred Stock+37.49%52-week change50.41P/E (Trailing)‪1.25%‬Profit Margin
- SINTLSELeverage Shares IncomeShares Intel (INTC) Options ETP+96.32%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 0A4M - DexCom, Inc.
About
Dexcom Inc. is a medical device company specializing in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for diabetes management and metabolic health in the United States and internationally. Its CGM systems provide real-time glucose data as an alternative to traditional…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
